R&D Partner Content Returning for a 4th Year... GPCRs-Targeted Drug Discovery! Transforming the Discovery of Novel GPCR-Targeted Therapies
R&D Partner Content 2nd ESG in Life Sciences Summit Europe Mastering Life Science ESG Compliance & Strategic Impact in 2025
R&D Partner Content 6th GxP Cloud Compliance Summit 2025 Advancing AI Advancing AI Validation, Risk Management, and Cloud Security to Ensure GxP Cloud Compliance
R&D Partner Content Innovation in Psychosis Therapeutics Summit Join leaders at the Innovation in Psychosis Therapeutics Summit to revolutionize psychosis treatment
R&D Partner Content 4th ALS Drug Development Summit Join 200+ experts at the 4th ALS Summit to advance biomarkers, targets, and trials for ALS & FTD
R&D Partner Content 5th Medical Device Software Development Summit The 5th Medical Device Software Development Summit is your must-attend opportunity to gain actionable strategies, real-world case studies, and expert insights to confidently develop, secure, and re
News Beren's Niemann-Pick drug Lembaz cleared by FDA The FDA has approved Beren's Lembaz for Niemann-Pick disease type C, the first drug shown to extend survival in the ultra-rare inherited disorder.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.